Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Guidant Shifts To Everolimus As Stents Developed With Cook Under-Achieve

Related Content

Cook Reconsiders Logic Of Drug-Eluting Stents As Guidant Deal Unravels

Jan 06 2003

Cook ELUTES Study Delivers 3% Restenosis Rate In High-Dose Arm

Nov 19 2001

Cypher Impresses FDA Panel; Approval Recommended With More Drug Data

Oct 28 2002

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window